DocMorris
  • About us
    • Profile
    • Strategy
    • Business
      • Business fields
      • Markets & brands
    • Sustainability
    • History

    Commitment at all levels: Our sustainability ambition of a “Healthier life” guides our daily actions.

    Read more
  • Investor Relations
    • Investor hub
    • Newsroom
    • Financial publications
    • Investment highlights
    • Corporate governance
      • Governance principles
      • Board of Directors
      • Executive Board
      • General Meeting
    • Financial calendar
    • Share
      • Share information
      • Analysts & consensus
    • Bonds

    Always up to date in our investor hub – the one-stop destination for all Group IR topics.

    Learn more
  • News
    • Newsroom
    • News service
    • Press materials

    DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024

    Read more
    DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
  • Careers
    • Jobs
    • Areas of work
    • Locations
    • Culture
    • Diversity & inclusion
    • Leadership

    Join the e-Health pioneers.

    Learn more
© 2023 Zur Rose Group AG
    DEEN
Read more
26 May 2023
Ad hoc announcement pursuant to Art. 53 LR
DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Read more
Read more
12 May 2023
Ad hoc announcement pursuant to Art. 53 LR
DocMorris (formerly Zur Rose Group) announces a tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Read more
Read more
11 May 2023
Corporate news
New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)
Read more
Zur Rose Group AG

Follow us

DocMorris

Sustainability Investor hub Newsroom Jobs

Brands

DocMorris PromoFarma by DocMorris TeleClinic

Terms & services

Contact Legal notice Privacy policy Imprint
Privacy settings © 2023 DocMorris AG
      DEEN